Study of Adoptive Immunotherapy With Donor-derived CMV-specific T Cells for Recipients of Allo-HSCT

NCT02988258 · clinicaltrials.gov ↗

PHASE1

Phase

SUSPENDED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Protocol being re-written to allow inclusion of more patients

Conditions

Haematological Malignancies
CMV Infection

Interventions

GENETIC: CMV-TCR transduced donor-derived T cells

Sponsor

University College, London